Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 107 results for "Zegerid"

ViiV Healthcare Begins Phase III Programme with dolutegravir/r...

First programme to evaluate dual HIV maintenance therapy with dolutegravir and rilpivirine ViiV Healthcare today announced the start of a Phase III clinical trial programme to evaluate the safety and efficacy of dolutegravir (Tivicay®) and ... FierceBiotech, 1 week ago
AP via Yahoo!

Salix Pharmaceuticals, Ltd. (SLXP) Q1 Earnings Preview: What To Expect

Salix Pharmaceuticals, Ltd. ( NASDAQ:SLXP ) is scheduled to announce its financial results for the first quarter of fiscal year 2015 (1QFY15) on Thursday, May 7 after the markets close. Analysts are expecting the company to report a significant ...
 Bidness Etc2 weeks ago Valeant raises Salix Pharmaceuticals bid to US$11.11Bn; Endo surrenders  Taipei Times Online2 months ago Valeant increases Salix bid; Endo pulls out of bidding  Los Angeles Times2 months ago Valeant raises Salix bid to $11.11bn  Arab News2 months ago

CMS spent $103 billion on Medicare Part D in 2013, $2.5 billion on Nexium

CMS spent $2.5 billion on the heartburn drug in 2013 on 8.2 million claims. Henry Powderly, Managing Editor The Center for Medicare and Medicaid Services spent more than $103 billion on prescription drugs in 2013 under the Medicare Part D ...
 Healthcare Finance News3 weeks ago

Valeant Pharmaceuticals raises its outlook for 2015 after finishing purchase of Salix

LAVAL, Que. Valeant Pharmaceuticals International Inc. said Wednesday it turned a profit in the first quarter, and the Canadian drugmaker raised its forecasts for the year after completing more acquisitions. The company reported a profit of ...
 Canadian Business Magazine3 weeks ago Valeant Raises Outlook After Completing Purchase of Salix  ABC News3 weeks ago

Ritter Pharmaceuticals Names Gastroenterology Industry Veteran Gerald T. Proehl to its Board of Directors

Gerry is a highly regarded pharmaceutical executive and his significant experience in gastroenterology, including building companies and developing products, is ideal for Ritter Pharma, said Ira Ritter, Chairman of the Board of Directors of Ritter ...
 World Energy Source1 month ago Ritter Pharmaceuticals, Inc. Names Gastroenterology Industry Veteran Gerald T. Proehl To Its Board Of Directors  FierceBiotech4 weeks ago
Daily Times

PPIs Linked to Kidney Failure in Seniors

(Reuters Health) -- Older patients taking proton pump inhibitors, a common remedy for heartburn and acid reflux, are two times more likely to be hospitalized with kidney failure than peers who don't take the pills, a study finds. While the side ...
 MedPage Today1 month ago Common heartburn drugs linked to kidney failure in the elderly  Yahoo! Canada1 month ago

Nearly 1/3 of Salix work force cut; new owner plans 'limited presence' in Raleigh

Updated Apr. 3, 2015 at 10:00 a.m. Nearly 1/3 of Salix work force cut; new owner plans 'limited presence' in Raleigh Salix Related Blog Posts Site Search By RICK SMITH, WRAL TechWire Editor Raleigh, N.C. — A total of 258 employees of ...
 Local Tech Wire1 month ago

Methods of treating hepatic encephalopathy

The application describes treatment of hepatic encephalopathy using gastrointestinal specific antibiotics. One example of a gastrointestinal specific antibiotic is rifaximin. Description of the Invention BACKGROUND Hepatic encephalopathy (HE) ...
 PharmCast2 months ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - Zegerid
Get updated on latest news & your favorite topics right in your inbox!
More     Less